Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19



Rating:

Share or cite this content

Citations should be made in the following way:
R. Di Tria (Torino, Italy), G. Ferrari (Torino, Italy), P. Righini (Torino, Italy), A. Marchisio (Torino, Italy), C. Caponnetto (Torino, Italy), V. Gallo (Torino, Italy), S. Bassini (Torino, Italy), R. Prota (Torino, Italy). Outcomes of patients with COVID-19 pneumonia treated with CPAP. 1079

Member's Comments

No comment yet.

Related content which might interest you: Outcomes in patients requiring CPAP for COVID-19 infection in non-ITU settings Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Outcomes of NPPV in patients with ARF due to AECOPD and associated obesity Source: Eur Respir J 2004; 24: Suppl. 48, 313s Year: 2004 Efficacy of α-tocoferol in the treatment of patients with pneumonia Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Impact of inhaled corticosteroid use on outcome in COPD patients hospitalised with pneumonia Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 Diagnosis and follow-up home-based program in OSA patients treated with CPAP Source: Eur Respir J 2005; 26: Suppl. 49, 724s Year: 2005 Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Outcomes of noninvasive ventilation in immunosuppressed patients with acute respiratory failure due to pneumonia Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 Characteristics and outcomes in patients with COPD receiving machanical ventilation: Indication, survival and occurance of ventilator-associated pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 14s Year: 2003 Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Predictors of mortality in COVID-19 patients requiring CPAP Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Mortality in acute patients treated with noninvasive ventilation (NIV) Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure Year: 2011 Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients Source: Eur Respir J 2004; 24: Suppl. 48, 548s Year: 2004 Risk of pneumonia or death in COPD outpatients treated with different lengths of corticosteroids Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Prognosis and evolution of COPD patients hospitalized and treated with non invasive ventilation Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013 Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study Source: Eur Respir J, 56 (4) 2001935; 10.1183/13993003.01935-2020 Year: 2020 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011 Compliance to ventilatory treatment in a cohort of patients on home CPAP or NIV: analysis by diagnosis, treatment type, and comorbidities Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Respiratory follow-up of patients treated with nusinersen Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019